MannKind Corp (USD)
MNKD
Overview
Key Information
Legal Documents
Financials

Overview

SectorHealthcare
Industry-
Day Range1.77 | 1.84
52-Wk Range- | -
Last Close1.81
Mkt Cap (m)385.78
Dividend yield-
ISINUS56400P7069
Volume1,507,493.00
Exchange VenueNAS

Company Profile

MannKind Corp is engaged in the discovery, development, and commercialization of therapeutic products for diseases such as diabetes and cancer. Its products and technologies include Afrezza, Dry powder formulation, Inhalation profiling, and others.

Key Information
Price/Earning-
Price/Book0.00
Price/Sales5.91
P/CF-
Rev Growth (3 year avg)-28.82
EPS Growth (3 year avg)-
Operating Margin % -73.78
Net Margin %-82.34
Return on Equity-
Debt/Equity-

Documents

Prospectus
en 07/05/2019
Annual Report
en 31/12/2019

Please refer to the below issuer website for further documents.

http://www.mannkindcorp.com

Financials

Income Statement
USD201420152016201720182019
Revenue (m)0.000.00174.7611.7527.8663.04
Operating Income (m)-179.63-204.2465.09-94.35-81.06-46.51
Net Income (m)-198.38-368.45125.66-117.33-86.98-51.90
Basic EPS-2.55-4.551.37-1.13-0.60-0.27
Avg. Diluted Shares Outstanding (m)77.0581.2392.09104.25144.14195.58
Balance Sheet
USD201420152016201720182019
Current Assets (m)201.1576.6577.4957.2281.8560.76
Non Current Assets (m)193.2949.7629.5827.3625.8532.97
Total Assets (m)394.44126.41107.0684.58107.7193.73
Current Liabilities (m)403.35268.3292.0587.6075.2465.62
Total Liabilities (m)------
Total Equity (m)-73.77-350.33-183.59-214.73-175.08-190.53
Cash Flows
USD201420152016201720182019
Operating Cash Flows (m)4.09-57.23-78.09-64.78-37.73-88.48
Capital Expenditure (m)-24.10-10.29-1.14--0.35-2.57
Figures are quoted in USD unless stated otherwise
-0.01 (-0.28%)
$
1.81
Last Price